Jürgen Heindl-Wruss

USPTO Granted Patents = 18 (Patent Applications = 8)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 55(Granted Patents)

Company Filing History:

Dynavax Technologies Corporation

patents

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12214033 - Virus purification (2025-02-04),

2. 12102673 - Zika virus vaccine (2024-10-01),

3. 12011477 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3 (2024-06-18),

4. 12005111 - Zika virus vaccine (2024-06-11),

5. 11951163 - Zika virus vaccine (2024-04-09),

6. 11684669 - CpG-adjuvanted SARS-CoV-2 virus vaccine (2023-06-27),

7. 11524064 - Zika virus purification (2022-12-13),

8. 11484587 - Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3 (2022-11-01),

9. 11406700 - Virus purification (2022-08-09),

10. 11357846 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3 (2022-06-14),

11. 11331382 - Zika virus purification (2022-05-17),

12. 11219681 - Zika virus vaccine (2022-01-11),

13. 11207397 - Virus purification (2021-12-28),

14. 11110170 - Aluminum compounds for use in therapeutics and vaccines (2021-09-07),

15. 10668146 - Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines (2020-06-02),

Title: The Innovative Contributions of Jürgen Heindl-Wruss

Introduction

Jürgen Heindl-Wruss is a notable inventor based in Vienna, Austria. With an impressive portfolio of 16 patents, Heindl-Wruss has made significant strides in the field of biochemistry and virology.

Latest Patents

Among his latest innovations, Heindl-Wruss has developed methods for virus purification, particularly focusing on processes that purify infectious virus particles using protamine. Additionally, he has been instrumental in creating Zika virus vaccines, detailing compositions and methodologies for producing and administering these vaccines effectively to those in need.

Career Highlights

Heindl-Wruss has had a distinguished career, working with prominent organizations such as Valneva Austria GmbH and Valneva SE. His contributions within these companies have been pivotal in advancing research and development initiatives in virology.

Collaborations

Throughout his career, Heindl-Wruss has collaborated with talented colleagues, including Mario Nebenführ and Michael Weber. These partnerships have fostered a collaborative environment that underscores the importance of teamwork in scientific innovation.

Conclusion

Jürgen Heindl-Wruss is an exemplary inventor whose work continues to influence the fields of virology and vaccine development. His pioneering patents reflect his commitment to advancing healthcare solutions and highlight the critical role of innovation in addressing public health challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

8 patents pending:

Please report any incorrect information to support@idiyas.com

4 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.